Breast cancer drug fulvestrant appears more effective in the presence of CK8 and CK18
Monday, March 15, 2010 - 09:14
in Health & Medicine
Women's responsiveness to the second-line breast cancer drug fulvestrant may depend on whether the cancer cells are expressing two key proteins, Indiana University Bloomington scientists report in this month's Cancer Biology and Therapy...